Cited by 275

Contributions of central and systemic inflammation to the pathophysiology of Parkinson's disease

Collins, Louise M., Toulouse, André, Connor, Thomas J., Nolan, Yvonne M.·2012·Neuropharmacology

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.neuropharm.2012.01.028

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Dysregulation of microglia functions contributes to the pathogenesis of neurodegenerative diseases including Alzheimer's disease, Parkinson's disease and Huntington's disease.

    “Dysregulation of microglia functions contribute to the pathogenesis of neurodegenerative diseases, including Alzheimer’s disease (AD) (6–8), Parkinson’s disease (PD) (9–12) and Huntington’s disease (HD) (13–15).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 8

  1. Asadullah, K., Sterry, W., Volk, H. D., 2003. Interleukin-10 therapy--review of a new approach. Pharmacol Rev 55, 241-269.
  2. Chauveau, F., Boutin, H., Van Camp, N., Dolle, F., Tavitian, B., 2008. Nuclear imaging of neuroinflammation: a comprehensive review of [11C]PK11195 challengers. Eur J Nucl Med Mol Imaging 35, 2304-2319.
  3. Chen, H., O'Reilly, E. J., Schwarzschild, M. A., Ascherio, A., 2008b. Peripheral inflammatory biomarkers and risk of Parkinson's disease. Am J Epidemiol 167, 90-95.
  4. Miller, A.-M., Deighan, B., Nolan, Y., Lynch, M. A., 2011. Analysis of the impact of CD200 on neurodegenerative diseases. In: Chuen-Chung Chang, R., (Ed), Neurodegenerative Diseases. InTech Open Access Publisher, In Press.
  5. Orr, C. F., Rowe, D. B., Halliday, G. M., 2002. An inflammatory review of Parkinson's disease. Prog Neurobiol 68, 325-340.
  6. Samii, A., Etminan, M., Wiens, M. O., Jafari, S., 2009. NSAID use and the risk of Parkinson's disease: systematic review and meta-analysis of observational studies. Drugs Aging 26, 769-779.
  7. Stolp, H. B., Dziegielewska, K. M., 2009. Review: Role of developmental inflammation and blood-brain barrier dysfunction in neurodevelopmental and neurodegenerative diseases. Neuropathol Appl Neurobiol 35, 132-146.
  8. Tse, W., Cersosimo, M. G., Gracies, J. M., Morgello, S., Olanow, C. W., Koller, W., 2004. Movement disorders and AIDS: a review. Parkinsonism Relat Disord 10, 323-334.

Cited by

Sorted by citations

Authors
Collins, L. M., Toulouse, A., Connor, T. J., & Nolan, Y. M.
Venue
Neuropharmacology
Publisher
Elsevier BV
Published
2012-06
Volume
62
Issue
7
Pages
2154-2168
ISSN
0028-3908
Cited by
275
References
25
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review